SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Cash Flow
FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 134.81M | 150.34M | 151.93M | 125.80M | 101.20M | |||
| Depreciation Amortization | 68.88M | 64.98M | 46.65M | 55.40M | 36.40M | |||
| Income Taxes - Deferred | -9.68M | -4.23M | 836.00K | 3.10M | 1.70M | |||
| Change In Working Capital | -12.20M | 16.70M | -15.67M | -27.30M | -17.00M | |||
| Interest Paid | 12.41M | 10.56M | 6.66M | 1.80M | 1.20M | |||
| Taxes Paid | 28.96M | 29.73M | 31.68M | 29.80M | 21.40M | |||
| Other non cash items | 1.88M | -2.47M | -2.10M | 25.00M | 9.90M | |||
| OPERATING CASH FLOW | 183.69M | 225.33M | 181.65M | 182.10M | 132.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -137.95M | -145.30M | -175.52M | -152.70M | -98.60M | |||
| Other Investing Activity | -334.00K | -633.00K | 4.11M | 10.60M | 2.70M | |||
| INVESTING CASH FLOW | -138.28M | -145.93M | -171.41M | -142.10M | -95.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -4.95M | -3.56M | -3.49M | -1.50M | -1.50M | |||
| Dividend Paid | N/A | -22.59M | -18.88M | N/A | N/A | |||
| Other Financing Activity | -20.33M | -52.01M | 10.97M | -40.90M | -26.00M | |||
| FINANCING CASH FLOW | -47.88M | -78.16M | -11.39M | -42.40M | -27.50M | |||
| Exchange Rate Effect | -2.10M | -2.42M | -3.28M | 3.30M | 400.00K | |||
| CHANGE IN CASH | -4.56M | -1.18M | -4.44M | 900.00K | 9.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 183.69M | 225.33M | 181.65M | 182.10M | 132.20M | |||
| Capital Expenditure | -137.95M | -145.30M | -175.52M | -152.70M | -98.60M | |||
| FREE CASH FLOW | 45.75M | 80.03M | 6.13M | 29.40M | 33.60M | |||
All data in EUR